Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients
Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if using preventive treatments such as Doxycycline
(an anti-biotic) capsules, sunscreen with SPF 30, Hydrocortisone 1% cream and a moisturizer
will help to reduce the incidence and severity of the skin rash associated with Cetuximab
(Erbitux®) when compared to receiving standard care for the treatment of skin rash.
Phase:
Phase 2
Details
Lead Sponsor:
James Graham Brown Cancer Center University of Louisville
Collaborators:
James Graham Brown Cancer Center University of Louisville